Effect of vildagliptin add-on treatment to metformin on plasma asymmetric dimethylarginine in type 2 diabetes mellitus patients

Mustafa Cakirca1 Internal Medicine Clinic, Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkey

Cumali Karatoprak1 Internal Medicine Clinic, Faculty of Medicine, Bezmialem Vakif University, Istanbul, TurkeyCorrespondence[email protected]

Mehmet Zorlu1 Internal Medicine Clinic, Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkey

Muharrem Kiskac1 Internal Medicine Clinic, Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkey

Mustafa Kanat2 Department of Internal Medicine, Medical Faculty, Istanbul Medipol University, Istanbul, Turkey

Mehmet Ali Cikrikcioglu1 Internal Medicine Clinic, Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkey

Pinar Soysal3 Department of Geriatric Medicine, Medical Faculty, Dokuz Eylül University, Istanbul, Turkey

Mehmet Hursitoglu4 Department of Internal Medicine, Kanuni Sultan Suleyman Training and Research Hospital, Istanbul, Turkey

Ahmet Adil Camli1 Internal Medicine Clinic, Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkey

Reha Erkoc1 Internal Medicine Clinic, Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkey

Muhammad Abdul-Ghani5 Division of Medicine – Diabetes, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA

Articles from other publishers (1)